Product Information
XYOSTED 75 MG/0.5 ML AUTO-INJ is a brand product labeled by Antares Pharma, Inc., priced at $316.3804 per ML under NDC 54436027504. Its NADAC has been published 385 times since May 22, 2019.
FDA first approved this application on Sep 28, 2018.
Strength
75 mg/.5mL
Manufacturer
Antares Pharma, Inc.NDC
54436027504
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONE ENANTHATEApproval Type
New Drug (NDA)
FDA Application
NDA209863FDA Approved
9/28/2018
On Market Since
11/15/2018
Pharmacological Classes
Price Statistics
The NADAC for XYOSTED 75 MG/0.5 ML AUTO-INJ has been published 385 times since May 22, 2019, and over the history we have for it it has risen 39.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $316.3804 per ML |
|---|---|
| All-time high | $316.8468 (May 13, 2026) |
| All-time low | $226.5200 (May 22, 2019) |
| 52-week high | $316.8468 |
| 52-week low | $307.5750 |
| Median price | $289.8119 |
| Average price | $278.4505 |
| Largest weekly change | +5.0% (Jul 10, 2019) |
| Weeks tracked | 385 |
| Tracking since | May 22, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the testosterone enanthate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Antares Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
testosterone enanthate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XYOSTED 75 MG/0.5 ML AUTO-INJ?
The current National Average Drug Acquisition Cost (NADAC) for XYOSTED 75 MG/0.5 ML AUTO-INJ, manufactured by Antares Pharma, Inc., is $316.3804 per ML (NDC 54436027504), effective Sep 30, 2026.
How has the price of XYOSTED 75 MG/0.5 ML AUTO-INJ changed over time?
Over the history we have for it, the NADAC for XYOSTED 75 MG/0.5 ML AUTO-INJ has risen 39.7%. It has been tracked across 385 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for XYOSTED 75 MG/0.5 ML AUTO-INJ?
Since May 22, 2019, the NADAC for XYOSTED 75 MG/0.5 ML AUTO-INJ has ranged from a low of $226.5200 (May 22, 2019) to a high of $316.8468 (May 13, 2026), with a median of $289.8119 per ML.
Are there cheaper alternatives to XYOSTED 75 MG/0.5 ML AUTO-INJ?
No other NADAC-published product currently shares the active ingredient and strength of XYOSTED 75 MG/0.5 ML AUTO-INJ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XYOSTED 75 MG/0.5 ML AUTO-INJ?
XYOSTED 75 MG/0.5 ML AUTO-INJ (NDC 54436027504) is labeled by Antares Pharma, Inc., and CMS classifies it as a brand product.